CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while ...
The Centers for Medicare & Medicaid Services Dec. 23 introduced a new drug pricing model, BALANCE, for Medicare Part D and ...
MedPage Today on MSN
New CMS Demo Aims to Increase Access to GLP-1s Under Medicaid and Part D
The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for ...
The U.S. Centers for Medicare and Medicaid Services on Tuesday unveiled a voluntary program to cover GLP-1 drugs for weight-loss and diabetes under Medicaid and Medicare Part D plans, following the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback